Status:
COMPLETED
Diets, Lipoproteins and Inflammation Markers
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Conditions:
Cardiovascular Diseases
Metabolic Syndrome
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Systematic inflammation and lipid profiles are two major therapeutic targets for cardiovascular diseases. The effectiveness of vegan diet has been reported (doi: 10.3389/fnut.2022.807810). Aim: To c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with dyslipidemia (at least one of the following)
- TG ≥ 150 mg/dL
- TC ≥ 200 mg/dL
- LDL-c≥ 130 mg/dL,
- HDL-c \< 45 mg/dL for male or \< 55 mg/dL for female or receiving statin treatment
- Exclusion Criteria (fulfill one of the following condition):
- chronic kidney disease
- history of coronary artery disease
- ischemic heart disease,
- heart failure,
- stroke,
- cancer of any type
Exclusion
Key Trial Info
Start Date :
July 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05423457
Start Date
July 18 2017
End Date
June 15 2018
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hualien Tzu Chi Hospital
Hualien City, Taiwan